Sectors

CLB
Core Laboratories Inc.
12.43
100 x 12.42
200 x 12.47
bid
ask
+
0.07
0.57%
150 @ 04:15 PM
12.43 +0.00 (0.00%)
Ytd-22.46%
1y7.99%
12.38
day range
12.86
9.79
52 week range
20.36
Open12.60Prev Close12.36Low12.38High12.86Mkt Cap570.34M
Vol581.16KAvg Vol838.40KEPS0.52P/E23.90Forward P/E17.18
Beta2.36Short Ratio23.15Inst. Own112.62%Dividend0.04Div Yield0.24
Ex Div Date11-04Earning10-2850-d Avg11.55200-d Avg15.101yr Est19.33

CLB News

BlackRock Inc. Makes New Investment in Core Laboratories Inc. $CLB
defenseworld.net
BlackRock Inc. Makes New Investment in Core Laboratories Inc. $CLB

BlackRock Inc. acquired a new stake in Core Laboratories Inc. (NYSE: CLB) during the second quarter,

Core Laboratories (CLB) Up 18.7% Since Last Earnings Report: Can It Continue?
zacks.com
Core Laboratories (CLB) Up 18.7% Since Last Earnings Report: Can It Continue?

Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?

Advisors Capital Management LLC Makes New $2.77 Million Investment in Core Laboratories Inc. $CLB
defenseworld.net
Advisors Capital Management LLC Makes New $2.77 Million Investment in Core Laboratories Inc. $CLB

Advisors Capital Management LLC purchased a new stake in Core Laboratories Inc. (NYSE: CLB) during t

John Rogers Buys Core Laboratories Inc (CLB) -- Shares Look 28% Undervalued on GF Value
gurufocus.com
John Rogers Buys Core Laboratories Inc (CLB) -- Shares Look 28% Undervalued on GF Value

On June 30, 2026, John Rogers (Trades, Portfolio), founder of Ariel Investment, LLC, increased the f

DTI or CLB: Which Is the Better Value Stock Right Now?
zacks.com
DTI or CLB: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Oil and Gas - Field Services sector might want to consider eithe

Is CLB Stock Attractive After Its Sharp Selloff and Mixed Q2 Results?
zacks.com
Is CLB Stock Attractive After Its Sharp Selloff and Mixed Q2 Results?

Core Laboratories stock looks cheaper after a 47.1% six-month selloff, but falling earnings and geop

Core Laboratories Q2 Earnings Beat Estimates, Decline Y/Y
zacks.com
Core Laboratories Q2 Earnings Beat Estimates, Decline Y/Y

CLB's Q2 earnings top estimates despite lower revenues and profit as Production Enhancement strength

Core Laboratories Q2 Earnings Call Highlights
marketbeat.com
Core Laboratories Q2 Earnings Call Highlights

Core Laboratories NYSE: CLB reported second-quarter 2026 revenue of $124.6 million, up more than 2%

Core Laboratories Inc. (CLB) Q2 2026 Earnings Call Transcript
seekingalpha.com
Core Laboratories Inc. (CLB) Q2 2026 Earnings Call Transcript

Core Laboratories Inc. (CLB) Q2 2026 Earnings Call Transcript

Core Laboratories (CLB) Q2 Earnings Surpass Estimates
zacks.com
Core Laboratories (CLB) Q2 Earnings Surpass Estimates

Core Laboratories (CLB) came out with quarterly earnings of $0.11 per share, beating the Zacks Conse

benzinga.com
Core Laboratories Q2 Adj. EPS $0.11 Beats $0.09 Estimate, Sales $124.609M Miss $125.100M Estimate

Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.11 per share which beat the analyst c

CORE LAB REPORTS SECOND QUARTER 2026 RESULTS
prnewswire.com
CORE LAB REPORTS SECOND QUARTER 2026 RESULTS

REVENUE OF $ 124.6 MILLION, UP 2% SEQUENTIALLY AND DOWN 4% YEAR-OVER-YEAR OPERATING INCOME OF $ 9.2

benzinga.com
Core Laboratories Sees Q3 GAAP EPS $0.12-$0.20 vs $0.16 Est; Sees Sales $128.500M-$135.500M vs $131.

Core Laboratories (NYSE:CLB) is looking for Q3 GAAP EPS of $0.12-$0.20 vs $0.16 analyst estimate. se

Ariel Small/Mid Cap Value Q2 2026 Portfolio Activity
seekingalpha.com
Ariel Small/Mid Cap Value Q2 2026 Portfolio Activity

The Ariel Small/Mid Cap Value Composite rose +15.08% gross of fees (+14.95% net of fees) in the quar

What's in Store for Core Laboratories Stock in Q2 Earnings?
zacks.com
What's in Store for Core Laboratories Stock in Q2 Earnings?

CLB's Q2 may reflect resilient international activity and tariff insulation, but weaker reservoir de

Earnings Preview: Core Laboratories (CLB) Q2 Earnings Expected to Decline
zacks.com
Earnings Preview: Core Laboratories (CLB) Q2 Earnings Expected to Decline

Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likel

Core Stock Down 39% in 6 Months: Should You Hold or Sell Now?
zacks.com
Core Stock Down 39% in 6 Months: Should You Hold or Sell Now?

CLB struggles with ongoing headwinds from lower completion activity, operational disruptions, inflat

CORE LABORATORIES ANNOUNCES TIMING OF SECOND QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL
prnewswire.com
CORE LABORATORIES ANNOUNCES TIMING OF SECOND QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL

HOUSTON, June 30, 2026 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its second quarter

benzinga.com
Mobility Global To Replace Core Laboratories Effective Prior To The Opening Of Trading On Thursday,

https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20260626-1484136/1484136_spgi-se

Core Lab Stock Plunges 18% in 3 Months: Time to Hold or Fold?
zacks.com
Core Lab Stock Plunges 18% in 3 Months: Time to Hold or Fold?

CLB faces persistent geopolitical uncertainty, weaker laboratory activity, cost inflation and delaye

Arista Introduces Next-Generation 1.6Terabit Portfolio for AI Fabrics
gurufocus.com
Arista Introduces Next-Generation 1.6Terabit Portfolio for AI Fabrics

Arista Networks (NYSE: ANET), a leader in modern AI fabric networking, today announced the Arista [u

Core Laboratories (CLB) Down 4.9% Since Last Earnings Report: Can It Rebound?
zacks.com
Core Laboratories (CLB) Down 4.9% Since Last Earnings Report: Can It Rebound?

Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?

Implied Volatility Surging for Core Laboratories Stock Options
zacks.com
Implied Volatility Surging for Core Laboratories Stock Options

Investors need to pay close attention to CLB stock based on the movements in the options market late

Top 3 Energy Stocks That May Jump In Q2
benzinga.com
Top 3 Energy Stocks That May Jump In Q2

Opportunity to buy undervalued energy stocks as RSI shows oversold levels. NCS Multistage, Core Labo

benzinga.com
Core Laboratories Sees Q2 GAAP EPS $0.06-$0.12 vs $0.09 Est; Sees Sales $123.000M-$131.000M vs $127.

Core Laboratories (NYSE:CLB) is looking for Q2 GAAP EPS of $0.06-$0.12 vs $0.09 analyst estimate. se

benzinga.com
Core Laboratories Q1 Adj. EPS $0.06 Misses $0.11 Estimate, Sales $121.797M Miss $124.935M Estimate

Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.06 per share which missed the analyst

Earnings Scheduled For April 29, 2026
benzinga.com
Earnings Scheduled For April 29, 2026

benzinga.com
Core Laboratories Sees Q1 Adj EPS $0.05-$0.07 vs $0.14 Est; Lowers Q1 Sales Guidance from $124.000M-

Core Laboratories (NYSE:CLB) is looking for Q1 Adj EPS of $0.05-$0.07 vs $0.14 analyst estimate. Low

benzinga.com
Core Laboratories Sees Q1 GAAP EPS $0.11-$0.15 vs $0.15 Est; Sees Sales $124.000M-$130.000M vs $128.

Core Laboratories (NYSE:CLB) is looking for Q1 GAAP EPS of $0.11-$0.15 vs $0.15 analyst estimate. se

benzinga.com
Core Laboratories Q4 Adj. EPS $0.21 Beats $0.19 Estimate, Sales $138.255M Beat $131.100M Estimate

Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.21 per share which beat the analyst c

Earnings Scheduled For February 4, 2026
benzinga.com
Earnings Scheduled For February 4, 2026

P/E Ratio Insights for Core Laboratories
benzinga.com
P/E Ratio Insights for Core Laboratories

Las Vegas Sands Posts Upbeat Q3 Results, Joins Garrett Motion, LendingClub, Dow, Hexcel And Other Big Stocks Moving Higher On Thursday
benzinga.com
Las Vegas Sands Posts Upbeat Q3 Results, Joins Garrett Motion, LendingClub, Dow, Hexcel And Other Bi

benzinga.com
Earnings Scheduled For October 22, 2025

benzinga.com
A Preview Of Core Laboratories's Earnings

benzinga.com
Earnings Scheduled For July 23, 2025

benzinga.com
Core Laboratories's Earnings Outlook

benzinga.com
Stifel Maintains Hold on Core Laboratories, Lowers Price Target to $12

Stifel analyst Stephen Gengaro maintains Core Laboratories (NYSE:CLB) with a Hold and lowers the

benzinga.com
Citigroup Maintains Neutral on Core Laboratories, Lowers Price Target to $13

Citigroup analyst Scott Gruber maintains Core Laboratories (NYSE:CLB) with a Neutral and lowers t

benzinga.com
Core Laboratories Sees Q2 GAAP EPS $0.17-$0.21 vs $0.24 Est; Sees Sales $128.000M-$134.000M vs $136.

Core Laboratories (NYSE:CLB) is looking for Q2 GAAP EPS of $0.17-$0.21 vs $0.24 analyst estimate. se

benzinga.com
Core Laboratories Q1 Adj. EPS $0.14 Misses $0.19 Estimate, Sales $123.58M Miss $129.80M Estimate

Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.14 per share which missed the analyst

benzinga.com
Earnings Scheduled For April 23, 2025

benzinga.com
Examining the Future: Core Laboratories's Earnings Outlook

benzinga.com
Stifel Maintains Hold on Core Laboratories, Lowers Price Target to $15

Stifel analyst Stephen Gengaro maintains Core Laboratories (NYSE:CLB) with a Hold and lowers the

Tesla To $120? Here Are 10 Top Analyst Forecasts For Wednesday
benzinga.com
Tesla To $120? Here Are 10 Top Analyst Forecasts For Wednesday

benzinga.com
Citigroup Upgrades Core Laboratories to Neutral, Raises Price Target to $16

Citigroup analyst Scott Gruber upgrades Core Laboratories (NYSE:CLB) from Sell to Neutral and rai

benzinga.com
Citigroup Maintains Sell on Core Laboratories, Raises Price Target to $15

Citigroup analyst Scott Gruber maintains Core Laboratories (NYSE:CLB) with a Sell and raises the

benzinga.com
Core Laboratories Q4 2024 Adj EPS $0.22, Inline, Sales $129.24M Miss $132.44M Estimate

Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.22 per share which met the analyst co

benzinga.com
Insights into Core Laboratories Q4 Earnings

benzinga.com
Earnings Scheduled For January 29, 2025